|  Help  |  About  |  Contact Us

Publication : Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway.

First Author  Valujskikh A Year  2002
Journal  Nat Immunol Volume  3
Issue  9 Pages  844-51
PubMed ID  12172545 Mgi Jnum  J:183981
Mgi Id  MGI:5319696 Doi  10.1038/ni831
Citation  Valujskikh A, et al. (2002) Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 3(9):844-51
abstractText  To prevent bystander destruction of healthy host tissues, cytotoxic CD8(+) T lymphocytes are fitted with specific receptors that direct their destructive forces specifically against chosen targets. We show here, however, that anti-H-Y monospecific, H-2(b-restricted MataHari CD8(+) T cells reject H-2(k) male skin grafts, with which they cannot directly interact. Such rejection is interferon-gamma-dependent and only occurs if the recipient endothelium expresses H-2(b). The findings suggest an alternate indirect effector pathway that requires processing and presentation of the donor H-Y antigen by recipient endothelium and have implications for both transplantation and autoimmune disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression